Prof. Vlad Ratziu discusses the updated subclassification and nomenclature for steatotic liver disease, the therapeutic advance of resmetirom, and the future for MASLD and MASH.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
This website doesn't track the visitors or use any cookies. Made by Alex Barredo. Send your feedback to alex@barredo.es.
